Zhejiang Hisun Pharmaceutical Co Ltd
600267.SS- Latest Trade
- trading higher13.17CNY
- Change
- 0.01
- % Change
0.08%Positive
- Day Range
- 13.10 - 13.68
- 52-Week Range
- 9.88 - 17.90
As of Jun 27 2022. Values delayed up to 15 minutes
- Previous Close
- 13.16
- Open
- 13.39
- Volume
- 23,587,186.00
- 3 Month Average Trading Volume
- 677.89
- Shares Out (Mil)
- 1,198.18
- Market Cap
- 15,768.07
- Forward P/E
- 26.48
- Dividend Yield
- 1.06
Key Statistics
2 mean rating - 1 analysts
- P/E Excl. Extra Items (TTM)
- 32.03
- Price To Sales (TTM)
- 1.31
- Price To Book (Quarterly)
- 2.05
- Price To Cash Flow (Per Share TTM)
- -99,999.99
- Total Debt/Total Equity (Quarterly)
- 110.91
- Long Term Debt/Equity (Quarterly)
- 39.41
- Return On Investment (TTM)
- 4.23
- Return On Equity (TTM)
- 2.33
2021 (millions USD)
About Zhejiang Hisun Pharmaceutical Co Ltd
Company Information
Zhejiang Hisun Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products. The Company's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The Company is also engaged in the sales of drugs manufactured by other companies. The Company distributes its products in domestic markets and to overseas markets.
Address
No. 46, Waisha Road, Jiaojiang DistrictTAIZHOU, ZHJ
318000
China
Industry
Major Drugs
Executive Leadership
- Guoping Jiang
- Chairman of the Board, Acting President
- Xiaohua Chen
- Vice Chairman of the Board
- Zhenying Zhang
- Chief Financial Officer
- Haibin Wang
- Senior Vice President, Director
- Shihong Cai
- Vice President, Director
- Rui Di
- Vice President
- Qiandao Gu
- Vice President
- Ling Jiang
- Vice President
- Burman Subrata Kumar
- Vice President
- Di Lin
- Vice President
- Jiali Luo
- Vice President
- Zhengli Tao
- Vice President
- Weibing Wang
- Vice President
- Shunbing Yu
- Vice President
- Tianmin Zhu
- Vice President
- Wei Zhang
- Secretary of the Board
- Jianqiu Lin
- Director
- Jianhua Wu
- Director
- Yunpei Guo
- Independent Director
- Chao Lu
- Independent Director
- Cheng Zhang
- Independent Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,820.90 | -- |
| Copper | 696.10 | 0.61%Positive |
| Brent Crude Oil | 116.26 | 1.02%Positive |
| CBOT Soybeans | 1,636.00 | 0.34%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,900.11 | 0.30%Negative |
| Euro STOXX 50 | 3,538.88 | 0.16%Positive |
| FTSE 100 | 7,258.32 | 0.69%Positive |
| Nikkei 225 | 26,974.90 | 0.39%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes